PT1156814E - Compostos farmaceuticos suplementos dieteticos e composicoes cosmeticas compreendendo um acido gordo e gengibre - Google Patents

Compostos farmaceuticos suplementos dieteticos e composicoes cosmeticas compreendendo um acido gordo e gengibre

Info

Publication number
PT1156814E
PT1156814E PT00907455T PT00907455T PT1156814E PT 1156814 E PT1156814 E PT 1156814E PT 00907455 T PT00907455 T PT 00907455T PT 00907455 T PT00907455 T PT 00907455T PT 1156814 E PT1156814 E PT 1156814E
Authority
PT
Portugal
Prior art keywords
cosmetic compositions
comprehensing
ginger
fatty acid
pharmaceutical compounds
Prior art date
Application number
PT00907455T
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Eurovita A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurovita A S filed Critical Eurovita A S
Publication of PT1156814E publication Critical patent/PT1156814E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT00907455T 1999-03-03 2000-03-02 Compostos farmaceuticos suplementos dieteticos e composicoes cosmeticas compreendendo um acido gordo e gengibre PT1156814E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199900293 1999-03-03

Publications (1)

Publication Number Publication Date
PT1156814E true PT1156814E (pt) 2004-01-30

Family

ID=8091922

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00907455T PT1156814E (pt) 1999-03-03 2000-03-02 Compostos farmaceuticos suplementos dieteticos e composicoes cosmeticas compreendendo um acido gordo e gengibre

Country Status (11)

Country Link
US (2) US6482421B2 (pt)
EP (1) EP1156814B1 (pt)
AT (1) ATE249231T1 (pt)
AU (1) AU2903300A (pt)
CA (1) CA2366318A1 (pt)
DE (1) DE60005152T2 (pt)
DK (1) DK1156814T3 (pt)
ES (1) ES2206195T3 (pt)
HK (1) HK1042240B (pt)
PT (1) PT1156814E (pt)
WO (1) WO2000051576A2 (pt)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485752B1 (en) * 2000-10-23 2002-11-26 Otto Torbjorn Hansen Composition and method for alleviating joint pain and stiffness
US6469384B2 (en) * 2001-02-01 2002-10-22 Fairchild Semiconductor Corporation Unmolded package for a semiconductor device
US7025985B2 (en) * 2001-05-28 2006-04-11 Kanebo, Ltd. Dihydroxyphenyl compounds and glucoside compounds thereof
WO2003030919A1 (es) * 2001-10-11 2003-04-17 Centro De Investigación Y Desarrollo De Medicamentos. Procedimiento de obtención de un extracto de jengibre
US6811796B2 (en) * 2002-04-22 2004-11-02 Matsuura Yakugyo Co., Ltd. Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
EP1638541B1 (en) * 2003-06-27 2010-05-19 Astellas Pharma Inc. Therapeutic agent for soft tissue sarcoma
US8633246B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
JP2005145900A (ja) * 2003-11-17 2005-06-09 Tsumura & Co 育毛剤組成物及び痒み抑制剤
US7338674B2 (en) * 2004-12-23 2008-03-04 Council Of Scientific And Industrial Research Anti-arthritic herbal composition and method thereof
KR100588469B1 (ko) 2005-02-21 2006-11-23 한국생명공학연구원 생강에서 분리된 쇼가올을 포함하는 비만의 예방 및 치료용조성물
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
US8017162B2 (en) * 2005-10-26 2011-09-13 Oryza Oil & Fat Chemical Co., Ltd. Anti-inflammatory agent
WO2007056811A1 (en) * 2005-11-16 2007-05-24 Natbio Pty Ltd Zingiber plant extract
WO2007066305A1 (en) * 2005-12-09 2007-06-14 Zelpy 2549 (Pty) Limited Compositions comprising sesquiterpene compounds for use in the prophylaxis or treatment of pain
DE102005062144A1 (de) * 2005-12-22 2007-08-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingwerfraktion zur Inhibierung humaner CYP Enzyme
DE102005062145A1 (de) * 2005-12-22 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingwerextrakt zur Inhibierung humaner Arzneistofftransporter
GB2436063A (en) 2006-03-16 2007-09-19 Nicholas John Larkins Pharmaceutical composition for the treatment of excess mucous production
JP5207341B2 (ja) * 2006-10-26 2013-06-12 独立行政法人産業技術総合研究所 炎症性サイトカイン産生抑制剤
US20080160116A1 (en) * 2006-12-07 2008-07-03 Herbalscience Singapore Pte. Ltd Compositions and Methods Comprising Zingiber Species
DE102007055344A1 (de) * 2007-11-19 2009-05-20 K. D. Pharma Bexbach Gmbh Neue Verwendung von Omega-3-Fettsäure(n)
PL2285242T3 (pl) * 2008-06-10 2013-09-30 Dsm Ip Assets Bv Kombinacje ekstraktu roślinnego i PUFA
DK2334295T3 (en) 2008-09-02 2017-10-09 Amarin Pharmaceuticals Ie Ltd PHARMACEUTICAL COMPOSITION COMPREHENSIVE EICOSAPENTAIC ACID AND NICOTIC ACID AND PROCEDURES FOR USING SAME
NZ627238A (en) 2009-04-29 2016-02-26 Amarin Pharmaceuticals Ie Ltd Stable pharmaceutical composition comprising ethyl eicosapentaenoate
MY198422A (en) 2009-04-29 2023-08-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
MY172372A (en) 2009-06-15 2019-11-21 Amarin Pharmaceuticals Ie Ltd Compositions and methods for lowering triglycerides
WO2011035166A1 (en) * 2009-09-18 2011-03-24 Phycoil Biotechnology International, Inc. Microalgae fermentation using controlled illumination
RU2758369C2 (ru) 2009-09-23 2021-10-28 Амарин Фармасьютикалз Айрлэнд Лимитед Фармацевтическая композиция, включающая омега-3 жирную кислоту и гидроксипроизводное статина, и способы ее применения
DE102009055917A1 (de) * 2009-11-27 2011-06-01 Beiersdorf Ag Verwendung von Zingeron gegen Altershaut
NZ587634A (en) * 2010-08-27 2013-10-25 Rato Health Ltd Transdermal Patch
KR101239055B1 (ko) 2010-09-03 2013-03-04 한국식품연구원 제론본 또는 이의 염을 유효성분으로 함유하는 비만예방 및 치료용 조성물
WO2012052848A1 (en) * 2010-10-21 2012-04-26 Innolipid, As Concentration of polyunsaturated fatty acids by distillation using removable isovolatile co-distilling agents
US20140127289A1 (en) 2010-11-29 2014-05-08 Armarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
FR2973227B1 (fr) * 2011-04-01 2014-08-08 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
FR2973228B1 (fr) * 2011-04-01 2014-08-01 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
TWI468170B (zh) 2011-07-18 2015-01-11 Univ Kaohsiung Medical 薑化合物之用途
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
EP2775837A4 (en) 2011-11-07 2015-10-28 Amarin Pharmaceuticals Ie Ltd METHODS OF TREATING HYPERTRIGLYCERIDEMIA
KR101174701B1 (ko) * 2011-12-29 2012-08-17 서울대학교산학협력단 진저레논 에이를 포함하는 비만 예방용 식품 조성물, 비만 치료용 약학조성물 및 비만 치료용 동물용 의약품
AU2013207368A1 (en) 2012-01-06 2014-07-24 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-CRP) in a subject
BR112014032905B1 (pt) 2012-06-29 2022-02-22 Amarin Pharmaceuticals Ireland Limited Uso de éster etílico do ácido eicosapentaenóico para redução do risco de morte cardiovascular, revascularização coronária e/ou angina instável em um indivíduo em terapia com estatina
WO2014031087A1 (en) * 2012-08-21 2014-02-27 Agricultural Research Develpoment Agency (Public Organization) Natural synergistic formulations containing andrographis paniculata extracts for supporting the inhibition of cartilate degradation in degenerative joint disease
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en) * 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
AU2014373611A1 (en) * 2013-12-24 2016-07-14 Innovative Herbal Products (Aust) Pty Ltd Treatment of pain
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
ES2855176T3 (es) * 2015-12-10 2021-09-23 Symrise Ag Composición con sabor y olor estabilizados
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
BR112019001799B1 (pt) * 2016-08-30 2022-04-05 Unilever Ip Holdings B.V. Composição para cuidados pessoais, processo para preparar uma composição e uso de uma composição
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
AU2019349563B2 (en) 2018-09-24 2023-06-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
CN113226058A (zh) * 2019-11-11 2021-08-06 弗门尼舍有限公司 姜酚化合物及其作为风味改良剂的用途
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure
WO2024171115A1 (en) * 2023-02-15 2024-08-22 Evithe Limited Methods of preparation of zingerone, compositions comprising zingerone, and uses therefor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01180822A (ja) * 1988-01-12 1989-07-18 Dainippon Pharmaceut Co Ltd 抗遅延型アレルギー剤
JPH07267856A (ja) * 1994-02-09 1995-10-17 Green Cross Corp:The 経口免疫抑制剤
GB9506837D0 (en) * 1995-04-03 1995-05-24 Scotia Holdings Plc Triglycerides
FR2752381B1 (fr) * 1996-08-13 1998-11-06 Pierre Moreau Biotechnologie aviaire, micro nutriments biodisponibles. prevention et traitement de la physiopathologie specifique des maladies de degenerescence et du vieillissement

Also Published As

Publication number Publication date
WO2000051576A2 (en) 2000-09-08
ES2206195T3 (es) 2004-05-16
DE60005152D1 (de) 2003-10-16
EP1156814B1 (en) 2003-09-10
HK1042240A1 (en) 2002-08-09
ATE249231T1 (de) 2003-09-15
US20020051800A1 (en) 2002-05-02
DK1156814T3 (da) 2004-01-12
EP1156814A2 (en) 2001-11-28
AU2903300A (en) 2000-09-21
DE60005152T2 (de) 2004-07-08
HK1042240B (zh) 2004-05-07
US6638525B2 (en) 2003-10-28
CA2366318A1 (en) 2000-09-08
US20030035853A1 (en) 2003-02-20
US6482421B2 (en) 2002-11-19
WO2000051576A3 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
PT1156814E (pt) Compostos farmaceuticos suplementos dieteticos e composicoes cosmeticas compreendendo um acido gordo e gengibre
ATE361066T1 (de) Polyungesättigen fettsäuren nährungsergänzung
WO2002043659A3 (en) Composition containing statins and calcium for improved cardiovascular health
ATE129894T1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
ATE411032T1 (de) Verwendungen von chitosanoligosacchariden
BR0013958A (pt) Dieta de elevado teor de lipìdios
DE60002581D1 (de) Zusammensetzung enthaltend butyrospermum parkii extrakte und die verwendung als arzneimittel oder nahrungszusatz
US20110142967A1 (en) Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
ATE338556T1 (de) Dihydrotriterpene bei der behandlung von virusinfektionen, herz und kreislauf krankheiten, entzündungen, überempfindlichkeiten oder schmerzen
ITFI20080243A1 (it) Formulazioni per la somministrazione orale di acidi grassi omega polienoici in combinazione con statine di origine naturale o semi-sintetica.
DE50000168D1 (de) Orale darreichungsform
JP2007261946A (ja) アシルアミノ酸亜鉛塩から成る炎症抑制剤
DE502004008870D1 (de) Verwendung omega-3-fettsäurehaltiger öle zur erhöhung der bioverfügbarkeit von pflanzenextrakten
AU2003224107A1 (en) Soluble composition containing sporopollenin and the use thereof
NO20022288D0 (no) Sammensetning til forebygging og/eller behandling av forstyrrelser forårsaket av abnorm lipid metabolisme, sominnbefatter propionyl L-karnitin og kitosan
WO2003002117A3 (en) Niaciamide and derivatives in combination with aminosugar
JP2006169192A (ja) 脂肪分解促進剤、皮膚外用組成物及び飲食品組成物
EP1474998B1 (en) Composition useful for weight control
WO2003097033A3 (fr) Nouvelle compositions neutraceutiques et pharmaceutiques et leurs utilisations
JP2006062968A (ja) むくみ改善剤
KR101229438B1 (ko) 항염증 활성을 갖는 오메가-3 계열 리소포스파티딜콜린 수산화물 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 항염증 조성물
RU92016045A (ru) Биологически активная добавка для косметических изделий
TH48498A3 (th) สารที่คล้ายแคพไซซินอยด์ชนิดใหม่ที่มีพันธะของเอสเตอร์
TH50745C3 (th) สารที่คล้ายแคพไซซินอยด์ชนิดใหม่ที่มีพันธะของเอสเตอร์